Cargando…

Prognostic Impact of Modulators of G proteins in Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer

The consequence of a loss of balance between G-protein activation and deactivation in cancers has been interrogated by studying infrequently occurring mutants of trimeric G-protein α-subunits and GPCRs. Prior studies on members of a newly identified family of non-receptor guanine nucleotide exchange...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbazan, Jorge, Dunkel, Ying, Li, Hongying, Nitsche, Ulrich, Janssen, Klaus-Peter, Messer, Karen, Ghosh, Pradipta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768264/ https://www.ncbi.nlm.nih.gov/pubmed/26916336 http://dx.doi.org/10.1038/srep22112

Ejemplares similares

Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling
por: Aznar, Nicolas, et al.
Publicado: (2015)

Two Isoforms of the Guanine Nucleotide Exchange Factor, Daple/CCDC88C Cooperate as Tumor Suppressors
por: Ear, Jason, et al.
Publicado: (2019)

Molecular Characterization of Circulating Tumor Cells in Human Metastatic Colorectal Cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Interferon-inducible CXC-chemokines are crucial immune modulators and survival predictors in colorectal cancer
por: Kistner, Larissa, et al.
Publicado: (2017)

A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer
por: Barbazán, Jorge, et al.
Publicado: (2012)

Prognostic Role of Circulating Tumor Cell Trajectories in Metastatic Colorectal Cancer
por: Magri, Valentina, et al.
Publicado: (2023)

Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma
por: Dunkel, Ying, et al.
Publicado: (2018)

Prediction of Metastasis and Recurrence in Colorectal Cancer Based on Gene Expression Analysis: Ready for the Clinic?
por: Shibayama, Masaki, et al.
Publicado: (2011)

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer
por: Cha, Yongjun, et al.
Publicado: (2016)

A Daple-Akt feed-forward loop enhances noncanonical Wnt signals by compartmentalizing β-catenin
por: Aznar, Nicolas, et al.
Publicado: (2017)

Clinical Characteristics of Metastatic Colorectal Cancer Combined with Gastrointestinal Perforation and Prognostic Value of Circulating Tumor DNA
por: Yang, Hong, et al.
Publicado: (2022)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer
por: Silva, Virgílio Souza e, et al.
Publicado: (2021)

Diagnostic and Prognostic Value of B4GALT1 Hypermethylation and Its Clinical Significance as a Novel Circulating Cell-Free DNA Biomarker in Colorectal Cancer
por: Picardo, Francesco, et al.
Publicado: (2019)

Retrospective study of prognosis of patients with multiple colorectal carcinomas: synchronous versus metachronous makes the difference
por: Barz, Christoph, et al.
Publicado: (2021)

Predictive and prognostic value of circulating blood lymphocyte subsets in metastatic breast cancer
por: Yang, Jian, et al.
Publicado: (2019)

Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients
por: Tsai, Wen-Sy, et al.
Publicado: (2016)

Colorectal cancer surgery remains effective with rising patient age
por: Nitsche, Ulrich, et al.
Publicado: (2014)

Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
por: Patelli, Giorgio, et al.
Publicado: (2023)

Heterotrimeric G proteins as emerging targets for network based therapy in cancer: End of a long futile campaign striking heads of a Hydra
por: Ghosh, Pradipta
Publicado: (2015)

High Circulating Methylated DNA Is a Negative Predictive and Prognostic Marker in Metastatic Colorectal Cancer Patients Treated With Regorafenib
por: Amatu, Alessio, et al.
Publicado: (2019)

Circulating guanylyl cyclase C (GCC) mRNA is a reliable metastatic predictor and prognostic index of colorectal cancer
por: Jiang, Lai, et al.
Publicado: (2020)

Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study
por: Salvianti, Francesca, et al.
Publicado: (2021)

Evaluation of the Prognostic Value of Low-Frequency KRAS Mutation Detection in Circulating Tumor DNA of Patients with Metastatic Colorectal Cancer
por: Lin, Chien-Yu, et al.
Publicado: (2023)

Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients
por: de Albuquerque, Andreia, et al.
Publicado: (2012)

Specific Mutations in APC, with Prognostic Implications in Metastatic Colorectal Cancer
por: Peng, Huan, et al.
Publicado: (2023)

Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
por: Brisotto, Giulia, et al.
Publicado: (2020)

Prognostic circulating proteomic biomarkers in colorectal liver metastases
por: Kim, Dongchan, et al.
Publicado: (2023)

KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer
por: Chou, Wen-Chi, et al.
Publicado: (2018)

Meta-analysis Reveals the Prognostic Value of Circulating Tumour Cells Detected in the Peripheral Blood in Patients with Non-Metastatic Colorectal Cancer
por: Lu, Yan-jun, et al.
Publicado: (2017)

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
por: Hansen, Torben Frøstrup, et al.
Publicado: (2017)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

Circulating cytokines and outcome in metastatic colorectal cancer patients treated with regorafenib
por: Ricci, Vincenzo, et al.
Publicado: (2020)

Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2019)

Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease
por: Povero, Davide, et al.
Publicado: (2014)

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review
por: Schraa, Suzanna J., et al.
Publicado: (2022)

Single-Cell Imaging of Metastatic Potential of Cancer Cells
por: Midde, Krishna, et al.
Publicado: (2018)

Genetic and immunological biomarkers predict metastatic disease recurrence in stage III colon cancer
por: Sperlich, Andreas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7eainejv730i5mgt4dh5ku5hv7